top of page
logo2.png
4.png

PDLLA + HA

LENISNA is a hybrid filler which have connected both benefits of immediate filling effect of HA (hyaluronic acid) and long-term stimulation of collagen production by  PDLLA (Poly D,L – lactide).

Thanks to the combination of PDLLA polylactic acid with HA hyaluronic acid, we obtain an effect that is visible immediately after the treatment. The filling is maintained until the production of new collagen, elastin, by polylactic acid begins to dominate.

Made in Korea

Features of Lenisna

  • the only hybrid formula in the world Poly D, L Lactide + HA with particle size from 50 to 60 micrometers

  • effectiveness and safety confirmed by clinical trials

  • durability of effects – over 2 years from the last treatment

  • immediate effect – due to hyaluronic acid

  • safety – FDA and CE certificates for polylactic acid

  • patents and own clinical trials

  • particle size from 50 to 60 microns

  • comfort of the procedure – easy injection and no needle clogging during the procedure

lenisna.png
Kuva1.jpg

Buttocks / Injection Buttlift

​Injection buttlift with Lenisna is the perfect tool for achieving a full voluminous round buttocks. The combination of PDLLA and HA in regards to creating lift and volume is very effective. There is an instant effect by the HA and with the long-term stimulation of collagen by the PDLLA - the buttocks stay firm and healthy for 2 years or more.

Suggested number of treatments and vials:

2-4 vials per session for 2-3 sessions, with 6-8 weeks between sessions.

kuva4.jpg

Clear signs of aging and lack of volume

Thanks to the combination of PDLLA polylactic acid with HA hyaluronic acid, we obtain an effect that is visible immediately after the treatment. The filling is maintained until the production of new collagen, elastin, by polylactic acid begins to dominate.

Suggested number of treatments and vials:

1 vials per session for 2-3 sessions, with 6-8 weeks between sessions.

Efficacy of PDLLA

According to the result of checking the effects of PDLLA+HA treatments on a total of 54 patients in Korea, in weeks 24 and 48 following the treatment, the treatment success rate* turned out to be 100% and 88.7%, respectively, which is very high

The treatment success rate by the period after PDLLA+HA treatment

* The rate of subjects whose WSRS(wrinkle severity rating scale) improved by 1point or

more at 24 and 48 weeks after the procedure compared to the baseline.

lenisna_efficacy.png
bottom of page